HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
10.13 USD
+0.03 (+0.3%)
10.13 USD
0 (0%)
Overall HLN gets a fundamental rating of 6 out of 10. We evaluated HLN against 191 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are some minor concerns on its financial health. HLN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HLN was profitable.
HLN had a positive operating cash flow in the past year.
HLN had positive earnings in each of the past 5 years.
Each year in the past 5 years HLN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.20%, HLN belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
With an excellent Return On Equity value of 8.92%, HLN belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
HLN's Return On Invested Capital of 6.11% is amongst the best of the industry. HLN outperforms 83.85% of its industry peers.
HLN had an Average Return On Invested Capital over the past 3 years of 6.15%. This is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
With an excellent Profit Margin value of 12.84%, HLN belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
HLN's Profit Margin has improved in the last couple of years.
The Operating Margin of HLN (21.31%) is better than 89.06% of its industry peers.
In the last couple of years the Operating Margin of HLN has grown nicely.
With a decent Gross Margin value of 60.75%, HLN is doing good in the industry, outperforming 69.79% of the companies in the same industry.
In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HLN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HLN has less shares outstanding
HLN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.31 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLN has a better Altman-Z score (2.31) than 60.42% of its industry peers.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
HLN has a better Debt to FCF ratio (5.11) than 82.29% of its industry peers.
HLN has a Debt/Equity ratio of 0.53. This is a neutral value indicating HLN is somewhat dependend on debt financing.
HLN has a worse Debt to Equity ratio (0.53) than 64.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.71
WACC8.63%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
HLN has a Current ratio of 0.98. This is amonst the worse of the industry: HLN underperforms 85.42% of its industry peers.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.78, HLN is not doing good in the industry: 84.38% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
Measured over the past years, HLN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
HLN shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
HLN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
The Revenue is expected to grow by 3.76% on average over the next years.
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.26 indicates a rather expensive valuation of HLN.
Compared to the rest of the industry, the Price/Earnings ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 80.21% of the companies listed in the same industry.
HLN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.92.
HLN is valuated rather expensively with a Price/Forward Earnings ratio of 17.42.
HLN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLN is cheaper than 79.17% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HLN to the average of the S&P500 Index (23.46), we can say HLN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.26 | ||
| Fwd PE | 17.42 |
4.2 Price Multiples
81.77% of the companies in the same industry are more expensive than HLN, based on the Enterprise Value to EBITDA ratio.
HLN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HLN is cheaper than 85.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.85 | ||
| EV/EBITDA | 15.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.53
PEG (5Y)1.15
EPS Next 2Y8.04%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.61, HLN pays a better dividend. On top of this HLN pays more dividend than 92.71% of the companies listed in the same industry.
HLN's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
10.13
+0.03 (+0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap45.11B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.45 (13.03%)
Short Float %0.29%
Short Ratio1.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)-3.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.26 | ||
| Fwd PE | 17.42 | ||
| P/S | 2.97 | ||
| P/FCF | 16.85 | ||
| P/OCF | 14.52 | ||
| P/B | 2.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.19 |
EPS(TTM)0.5
EY4.94%
EPS(NY)0.58
Fwd EY5.74%
FCF(TTM)0.6
FCFY5.94%
OCF(TTM)0.7
OCFY6.89%
SpS3.41
BVpS4.9
TBVpS-3.05
PEG (NY)3.53
PEG (5Y)1.15
Graham Number7.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.31 |
F-Score6
WACC8.63%
ROIC/WACC0.71
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.26 and the Price/Book (PB) ratio is 2.07.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 3 / 10.